Cite
HARVARD Citation
Ruan, Z. et al. (2021). The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review. Expert review of pharmacoeconomics & outcomes research. pp. 221-233. [Online].